In 2014, in an effort to inform and help steer research and development priorities for TB diagnostic tools, the World Health Organization released its high-priority target product profiles for new TB diagnostics.
As part of the revision process, WHO is initiating a public comment process for partners and stakeholders to provide inputs on the updated high-priority target product profiles for next-generation DST. Comments can be submitted from 7 – 31 January 2021, 18:00 CET.
The online survey tool can be accessed here: Proposed Target Product Profile for Next-Generation Drug-Susceptibility Testing at Peripheral Centres